Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Atassi

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
European Journal of Cancer & Clinical Oncology|October 1, 1984
Do we need new chemosensitive experimental models?G Atassi
Anti-Cancer Drugs|December 24, 1997
DNA topoisomerase targeting drugs: mechanisms of action and perspectivesH Malonne, G Atassi
European Journal of Cancer & Clinical Oncology|August 1, 1981
Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemiaR Verloes, G Atassi
European Journal of Cancer|September 1, 1975
R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectivenessG Atassi, H J Tagnon
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Drug interaction involving P-glycoprotein in relation to multidrug resistanceG Atassi, J P Tassin
European Journal of Cancer|July 1, 1974
Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L1210 leukemiaG Atassi, H J Tagnon
In Vivo (Athens, Greece)|January 1, 1990
Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenograftsP Dumont, G Atassi, P Roger
Investigational New Drugs|January 1, 1984
Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumorsG Atassi, P Hilgard, J Pohl
Anti-Cancer Drugs|April 1, 1994
Computer-assisted microscope analysis of morphonuclear modifications induced by anticancer antimetabolites in cell lines cultured in vitroO Pauwels, R Kiss, G Atassi
Carcinogenesis|July 27, 2001
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolJ Gusman, H Malonne, G Atassi
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
European Journal of Cancer & Clinical Oncology|October 1, 1984
Do we need new chemosensitive experimental models?G Atassi
Anti-Cancer Drugs|December 24, 1997
DNA topoisomerase targeting drugs: mechanisms of action and perspectivesH Malonne, G Atassi
European Journal of Cancer & Clinical Oncology|August 1, 1981
Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemiaR Verloes, G Atassi
European Journal of Cancer|September 1, 1975
R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectivenessG Atassi, H J Tagnon
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Drug interaction involving P-glycoprotein in relation to multidrug resistanceG Atassi, J P Tassin
European Journal of Cancer|July 1, 1974
Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L1210 leukemiaG Atassi, H J Tagnon
In Vivo (Athens, Greece)|January 1, 1990
Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenograftsP Dumont, G Atassi, P Roger
Investigational New Drugs|January 1, 1984
Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumorsG Atassi, P Hilgard, J Pohl
Anti-Cancer Drugs|April 1, 1994
Computer-assisted microscope analysis of morphonuclear modifications induced by anticancer antimetabolites in cell lines cultured in vitroO Pauwels, R Kiss, G Atassi
Carcinogenesis|July 27, 2001
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolJ Gusman, H Malonne, G Atassi
Pageof 19